BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31126600)

  • 1. Transjugular Portosystemic Shunt Reductions: A Retrospective Single-Center Experience.
    Joseph AS; Sandhu B; Khalil A; Lopera J
    J Vasc Interv Radiol; 2019 Jun; 30(6):876-884. PubMed ID: 31126600
    [TBL] [Abstract][Full Text] [Related]  

  • 2.  Percutaneous shunt reduction for the management of TIPS-induced acute liver decompensation: A follow-up study.
    De Keyzer B; Nevens F; Laenen A; Heye S; Laleman W; Verslype C; van der Merwe S; Maleux G
    Ann Hepatol; 2016 Nov-Dec 2016; 15(6):911-917. PubMed ID: 27740526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of transjugular intrahepatic portosystemic shunt induced refractory hepatic encephalopathy with the parallel technique: results of a clinical follow-up study.
    Maleux G; Heye S; Verslype C; Nevens F
    J Vasc Interv Radiol; 2007 Aug; 18(8):986-92; quiz 993. PubMed ID: 17675616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Techniques for Transjugular Intrahepatic Portosystemic Shunt Reduction and Occlusion.
    Taylor AG; Kolli KP; Kerlan RK
    Tech Vasc Interv Radiol; 2016 Mar; 19(1):74-81. PubMed ID: 26997091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes and Patency after Transjugular Intrahepatic Portosystemic Shunt Reduction for Overshunting Adverse Events.
    Shah RJ; Alqadi MM; Duvvuri M; Kim YJ; Tyagi R; Lokken RP; Gaba RC
    J Vasc Interv Radiol; 2022 Dec; 33(12):1507-1512. PubMed ID: 35964879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endovascular shunt reduction in the management of transjugular portosystemic shunt-induced hepatic encephalopathy: preliminary experience with reduction stents and stent-grafts.
    Maleux G; Verslype C; Heye S; Wilms G; Marchal G; Nevens F
    AJR Am J Roentgenol; 2007 Mar; 188(3):659-64. PubMed ID: 17312051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation.
    Charon JP; Alaeddin FH; Pimpalwar SA; Fay DM; Olliff SP; Jackson RW; Edwards RD; Robertson IR; Rose JD; Moss JG
    J Vasc Interv Radiol; 2004 Nov; 15(11):1219-30. PubMed ID: 15525740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Incidence of Hepatic Encephalopathy After Viatorr Controlled Expansion Transjugular Intrahepatic Portosystemic Shunt Creation.
    Kloster ML; Ren A; Shah KY; Alqadi MM; Bui JT; Lipnik AJ; Niemeyer MM; Ray CE; Gaba RC
    Dig Dis Sci; 2021 Nov; 66(11):4058-4062. PubMed ID: 33236314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel endovascular adjustable polytetrafluoroethylene-covered stent for the management of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
    Weintraub JL; Mobley DG; Weiss ME; Swanson E; Kothary N
    J Vasc Interv Radiol; 2007 Apr; 18(4):563-6. PubMed ID: 17446548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
    Saad WE; Darwish WM; Davies MG; Waldman DL
    J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory Hepatic Encephalopathy After Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors and Outcomes with Revision.
    Rowley MW; Choi M; Chen S; Hirsch K; Seetharam AB
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1765-1772. PubMed ID: 29872892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
    Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modified procedure for transjugular intrahepatic portosystemic shunt flow reduction.
    Jacquier A; Vidal V; Monnet O; Varoquaux A; Gaubert JY; Champsaur P; Gerolami R; Bartoli JM; Moulin G
    J Vasc Interv Radiol; 2006 Aug; 17(8):1359-63. PubMed ID: 16923985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Factors for Acute Transjugular Intrahepatic Portosystemic Shunt Occlusion Using Expanded Polytetrafluoroethylene-Covered Stent.
    Wang X; Luo X; Zhao M; Song J; Li X; Yang L
    Dig Dis Sci; 2020 Oct; 65(10):3032-3039. PubMed ID: 31853780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft.
    Hausegger KA; Karnel F; Georgieva B; Tauss J; Portugaller H; Deutschmann H; Berghold A
    J Vasc Interv Radiol; 2004 Mar; 15(3):239-48. PubMed ID: 15028808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of transjugular intrahepatic portosystemic shunt (TIPS)-associated refractory hepatic encephalopathy by shunt reduction using the parallel technique: outcomes of a retrospective case series.
    Cookson DT; Zaman Z; Gordon-Smith J; Ireland HM; Hayes PC
    Cardiovasc Intervent Radiol; 2011 Feb; 34(1):92-9. PubMed ID: 21057793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy.
    Pereira K; Carrion AF; Martin P; Vaheesan K; Salsamendi J; Doshi M; Yrizarry JM
    Liver Int; 2015 Dec; 35(12):2487-94. PubMed ID: 26332169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transjugular Intrahepatic Portosystemic Shunt Using the New Gore Viatorr Controlled Expansion Endoprosthesis: Prospective, Single-Center, Preliminary Experience.
    Miraglia R; Maruzzelli L; Di Piazza A; Mamone G; Caruso S; Gentile G; Tuzzolino F; Floridia G; Petridis I; Volpes R; Luca A
    Cardiovasc Intervent Radiol; 2019 Jan; 42(1):78-86. PubMed ID: 30073477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
    Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
    Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications During Transjugular Intrahepatic Portosystemic Shunt Creation.
    Shah RP; Sze DY
    Tech Vasc Interv Radiol; 2016 Mar; 19(1):61-73. PubMed ID: 26997090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.